IPO registrations (S-1, F-1) · Registrants
ASENSUS SURGICAL, INC.
- SEC CIK
- 876378 · filings on EDGAR ↗
- Name on the registration
- TRANSENTERIX, INC.
- Former names
- TRANSENTERIX, INC. (2019–2021); TRANSENTERIX INC. (2013–2019); SafeStitch Medical, Inc. (2008–2013); CELLULAR TECHNICAL SERVICES CO INC (1996–2008)
- Registration
- Form S-1, first filed 1996-07-02, last 2020-05-18; 2 initial registrations, 0 amendments
- Outcome
- Declared effective 2014-04-02; withdrawal requested 1996-07-19
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 1 TW ALEXANDER DRIVE, SUITE 160, Durham, NC 27703
- EIN
- 11-2962080
- EDGAR entity type
- operating
- Insiders and CEO pay
- ASENSUS SURGICAL, INC. on the corporate pages
Offering terms
- Shares offered
- 25,367,646
- Listing
- NYSE American under the symbol TRXC
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ASENSUS SURGICAL, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: CELLULAR TECHNICAL SERVICES COMPANY, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: ASENSUS SURGICAL, INC. EXACT (EIN (EXACT))
- Form D issuer: TRANSENTERIX INC. EXACT (CIK (EXACT))
- SEC filer: ASENSUS SURGICAL, INC. EXACT (CIK (EXACT))
- Person page: Richard C Pfenniger Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 17
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-07-02 | S-1 | S-1 (registration) | CELLULAR TECHNICAL SERVICES CO INC | 0000950117-96-000697 ↗ |
| 1996-07-19 | RW | RW (withdrawal request) | CELLULAR TECHNICAL SERVICES CO INC | 0000910680-96-000183 ↗ |
| 2009-07-02 | RW | RW (withdrawal request) | SafeStitch Medical, Inc. | 0001144204-09-035661 ↗ |
| 2009-07-02 | RW | RW (withdrawal request) | SafeStitch Medical, Inc. | 0001144204-09-035671 ↗ |
| 2014-04-02 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-14-000849 ↗ |
| 2014-12-19 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-14-003760 ↗ |
| 2016-03-11 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-16-003929 ↗ |
| 2016-03-11 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-16-003930 ↗ |
| 2016-06-22 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-16-004969 ↗ |
| 2017-05-19 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-17-001342 ↗ |
| 2018-01-29 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-18-000269 ↗ |
| 2018-04-17 | EFFECT | EFFECT (declared effective) | TRANSENTERIX INC. | 9999999995-18-000845 ↗ |
| 2020-02-10 | EFFECT | EFFECT (declared effective) | TRANSENTERIX, INC. | 9999999995-20-000310 ↗ |
| 2020-02-13 | EFFECT | EFFECT (declared effective) | TRANSENTERIX, INC. | 9999999995-20-000358 ↗ |
| 2020-05-18 | S-1 | S-1 (registration) | TRANSENTERIX, INC. | 0001193125-20-145069 ↗ |
| 2020-05-27 | EFFECT | EFFECT (declared effective) | TRANSENTERIX, INC. | 9999999995-20-001262 ↗ |
| 2022-04-28 | EFFECT | EFFECT (declared effective) | ASENSUS SURGICAL, INC. | 9999999995-22-001138 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-05-18 | S-1 | registration statement | $0.68 | 25,367,646 | $17,249,999 | NYSE American TRXC | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Frost Gamma Investments Trust | TenPercentOwner | 21 | 2007–2013 | ||
| FROST PHILLIP MD ET AL | Director; Director,TenPercentOwner; TenPercentOwner | 29 | 2007–2013 | ||
| KATZ STEPHEN | Director,Officer; Other | Chief Executive Officer | 3 | 2007–2008 | |
| ANGEL JOSHUA J | Director | 1 | 2007 | ||
| Block Kenneth | Officer | Chief Financial Officer | 1 | 2007 | |
| HSIAO JANE PH D | Director; Director,TenPercentOwner; Director,TenPercentOwnerOther | 30 | 2007–2021 | ||
| PFENNIGER RICHARD C JR | Director | 23 | 2007–2024 | person page Fuzzy | |
| Davis Stewart B | Officer | COO; COO & Secretary | 6 | 2007–2010 | |
| Filipi Charles | Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Medical Officer | 4 | 2007–2013 | |
| Rubin Steven D | Director | 8 | 2007–2013 | ||
| Spragens Jeffrey G | Director,Officer; Director,Officer,TenPercentOwner | CEO; President and CEO | 18 | 2007–2013 | |
| Heithoff Kenneth | Director | 4 | 2008–2009 | ||
| Wayne Kevin | Director | 8 | 2008–2013 | ||
| Jackson Adam S | Officer | CFO; Chief Financial Officer | 3 | 2008–2010 | |
| UniMed Investment Inc. | TenPercentOwner | 1 | 2009 | ||
| Chen Chao C | Director | 5 | 2009–2013 | ||
| Martin James Joseph | Officer | Chief Financial Officer | 4 | 2011–2013 | |
| AISLING CAPITAL III LP | Other; TenPercentOwner | 5 | 2013–2016 | ||
| Aisling Capital Partners III LLC | Other; TenPercentOwner | 5 | 2013–2016 | ||
| Aisling Capital Partners III LP | Other; TenPercentOwner | 5 | 2013–2016 | ||
| Dougherty Dennis | Director | 6 | 2013–2015 | ||
| ELMS STEVE | Other; TenPercentOwner | 5 | 2013–2016 | ||
| Jain Mudit K. | Other; TenPercentOwner | 4 | 2013–2016 | ||
| Kherani Aftab | Director | 9 | 2013–2019 | ||
| Mueller Richard | Officer | Chief Operating Officer | 4 | 2013–2014 | |
| Pope Todd | Director,Officer | President and CEO | 23 | 2013–2019 | |
| Purcell Dennis J | Other; TenPercentOwner | 5 | 2013–2016 | ||
| SCHIFF ANDREW N | Director,TenPercentOwner; Other; TenPercentOwner | 5 | 2013–2016 | ||
| Stack Richard S. | Other; TenPercentOwner | 5 | 2013–2016 | ||
| Starling William N JR | Director | 25 | 2013–2024 | ||
| SYNERGY LIFE SCIENCE PARTNERS L P | Other; TenPercentOwner | 4 | 2013–2016 | ||
| Synergy Venture Partners, LLC | Other; TenPercentOwner | 4 | 2013–2016 | ||
| LAVIOLETTE PAUL A | Director | 12 | 2013–2021 | ||
| Milne David Bruce | Director; TenPercentOwner | 18 | 2013–2024 | ||
| StepStone Group Holdings LLC | TenPercentOwner | 3 | 2013 | ||
| StepStone Group LP | TenPercentOwner | 3 | 2013 | ||
| StepStone PC GP, LLC | TenPercentOwner | 3 | 2013 | ||
| StepStone Pioneer Capital Buyout Fund II, L.P. | TenPercentOwner | 3 | 2013 | ||
| StepStone Pioneer Capital II, L.P. | TenPercentOwner | 3 | 2013 | ||
| StepStone-SYN Investments, L.L.L.P. | TenPercentOwner | 3 | 2013 | ||
| SV Life Sciences Fund IV (GP), L.P. | TenPercentOwner | 3 | 2013–2014 | ||
| SV LIFE SCIENCES FUND IV, L.P. | TenPercentOwner | 3 | 2013–2014 | ||
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. | TenPercentOwner | 3 | 2013–2014 | ||
| SVLSF IV, LLC | TenPercentOwner | 3 | 2013–2014 | ||
| SLATTERY JOSEPH P | Officer | EVP and CFO | 34 | 2013–2019 | |
| KELLEY WILLAM N | Director | 9 | 2015–2019 | ||
| Biffi Andrea | Director | 23 | 2015–2024 | ||
| SOFAR, S.p.A | TenPercentOwner | 2 | 2015–2017 | ||
| Fernando Anthony C. J. | Director,Officer; Officer | Chief Operating Officer; Chief Technology Officer; President and CEO | 24 | 2016–2024 | |
| Smith Eric A | Officer | Chief Commercial Officer | 5 | 2018–2020 | |
| Farabaugh Brett | Officer | Interim CFO | 4 | 2020 | |
| Shameze Rampertab | Officer | EVP, Chief Financial Officer | 12 | 2020–2024 | |
| Hobert Kevin J | Director | 5 | 2021–2024 | ||
| Kwo Elizabeth | Director | 6 | 2021–2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-09-15 | TRANSENTERIX INC. | Other Health Care | $950,000 | $950,000 | 1 | 1 |
| 2016-09-23 | TRANSENTERIX INC. | Other Health Care | $214,155 | $115,690 | 1 | 1 |
| 2012-02-27 | SafeStitch Medical, Inc. | Other Health Care | $8,317,600 | $8,317,600 | 36 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ASENSUS SURGICAL, INC. | NC | State business registries | name and state |
| Plan sponsor | ASENSUS SURGICAL, INC. | NC | Form 5500 (employee benefit plans) | name and state |
| Form D issuer | TRANSENTERIX INC. | NC | Form D private offerings | CIK (EXACT) |
| Paying company | Asensus Surgical, Inc. | NC | Open Payments (drug and device company payments) | name and state |
| SEC filer | ASENSUS SURGICAL, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | CELLULAR TECHNICAL SERVICES COMPANY, INC. | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | ASENSUS SURGICAL, INC. | EIN (EXACT) | ||
| Person page | Richard C Pfenniger Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NC first:
- CLOSURE MEDICAL CORP NC
- BAXANO SURGICAL, INC. NC
- Liquidia Technologies Inc NC
- MedPro Safety Products, Inc. NC
- Bioventus Inc. NC
- MIV THERAPEUTICS INC A1
- BIOCUREX INC A1
- Enox Biopharma Inc A1
- Stimcell Energetics Inc. A1
- EVOME MEDICAL TECHNOLOGIES INC. A1
In other datasets, the same topic (Technology) in NC:
- Form D issuer: 1336 Studios, LLC (Form D private offerings)
- Lobbying client: ACN INC (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology